Evident announced that it has completed its acquisition of Pramana, Inc., a provider of autonomous whole slide imaging systems for digital pathology. The transaction strengthens Evident’s position in the global digital pathology market and supports what the company describes as the next era of digital pathology solutions.
Pramana was founded in 2021 by nference and has developed a modular family of imaging and workflow systems that can process a broad range of specimens using real-time AI algorithms to optimize efficiency, reduce costs, and improve safety. The company’s technology is used across hospitals, research environments, and academic laboratories that are digitizing large volumes of pathology slides each day.
Evident has a longstanding history in clinical microscopy and optical imaging technologies. By integrating its platform with Pramana’s autonomous systems, Evident aims to enhance its digital pathology capabilities, supporting increased caseload volumes, automated quality control, seamless data integration workflows, and advanced imaging analytics powered by AI.
Evident stated that the acquisition comes at a time when healthcare providers, research institutions, and biotechnology organizations are rapidly shifting toward digital diagnostics solutions to improve accuracy, speed, and workload capacity. The combined product offering will enable customers to integrate digital imaging into routine operations and accelerate scientific and clinical decision-making.
Pramana’s leadership emphasized that the combination of real-time imaging automation and Evident’s optical precision has the potential to accelerate global adoption of digital pathology solutions and help laboratories modernize their diagnostic infrastructure.
KEY QUOTES:
“As the worldwide adoption of digital pathology continues to accelerate, our acquisition of Pramana represents a collaborative opportunity to expand our growing digital pathology product offering. Evident prides itself on pioneering new ways of helping the world see the unseen—this acquisition is an example of our commitment to bringing the most advanced solutions to our customers.”
Wes Pringle, CEO, Evident
“Pramana is dedicated to crafting solutions that empower labs to embrace digital transformation and modernize their workflows. We’ve seen remarkable enthusiasm for our autonomous whole slide imaging systems, and when combined with Evident’s long history of superior optics and proven performance, we see a significant opportunity to accelerate the global adoption of digital pathology and usher in a new era of intelligent imaging systems.”
Murali Aravamudan, Co-founder and CEO, nference and Pramana
